New Zealand markets closed

Prime Medicine, Inc. (PRME)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.14-0.19 (-3.56%)
At close: 04:00PM EDT
5.14 0.00 (0.00%)
After hours: 05:42PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
591
0
0
0
5,210
Operating expenses
Research development
154,799
147,905
86,725
70,550
2,980
Selling general and administrative
45,392
43,387
29,819
13,924
3,162
Total operating expenses
200,191
191,292
116,544
84,474
6,142
Operating income or loss
-199,600
-191,292
-116,544
-84,474
-932
Total other income/expenses net
-4,840
-7,120
-6,225
-81,379
-611
Income before tax
-204,440
-198,412
-122,769
-165,853
-1,543
Income tax expense
57
-279
-948
-486
1,867
Income from continuing operations
-204,497
-198,133
-121,821
-165,367
-3,410
Net income
-204,497
-198,133
-121,821
-165,367
-3,410
Net income available to common shareholders
-204,497
-198,133
-142,014
-184,119
-5,055
Basic EPS
-1.78
-
-4.19
-2.56
-0.07
Diluted EPS
-1.78
-
-4.19
-2.56
-0.07
Basic average shares
97,324
-
33,891
71,796
71,796
Diluted average shares
97,324
-
33,891
71,796
71,796